Clinical Trial: Axona (Caprylic Triglyceride) - National Multiple Sclerosis Society

Skip to navigation Skip to content

Clinical Trial: Axona (Caprylic Triglyceride)

Share

Details
Type of MS: PPMS|RRMS|SPMS
Treatment mode of action: To improve cognitive dysfunction
Number of Subjects: 158
Medication: Axona
Location: FL
Contact Information
Gloria Rodriguez
305-243-8052
GRodriguez13@med.miami.edu

Funding:

National MS Society

Description

Randomized, double-blinded, placebo-controlled study to evaluate safety, tolerability, and efficacy of Axona for improving cognitive dysfunction in people with MS.

Share